CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.
Schlüter A, Weller P, Kanaan O, Nel I, Heusgen L, Höing B, Haßkamp P, Zander S, Mandapathil M, Dominas N, Arnolds J, Stuck BA, Lang S, Bankfalvi A, Brandau S.
Schlüter A, et al. Among authors: nel i.
BMC Cancer. 2018 Mar 9;18(1):272. doi: 10.1186/s12885-018-4180-5.
BMC Cancer. 2018.
PMID: 29523110
Free PMC article.